Back to VA VANGUARD CAPITAL MANAGEMENT LLC

STOKSTOK
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in STOKE THERAPEUTICS INC

Yes. Vanguard Capital Management holds 2,586,937 shares of STOK (Stoke Therapeutics), worth $84.6M, as of its Q2 2026 13F filing. It increased the position by 231,334 shares (+9.8%) from Q1 2026. Vanguard Capital Management has held STOK in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$84.6M

Current Shares

2.6M

Total Value Change

+$7.9M

Total Shares Change

+231,334

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+9.8%
$84.6M0.0%$32.72
33
2026-Q1
First report
2.4M
-
$76.7M0.0%$33.78
0

Other major holders of STOK: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used